REGENXBIO Inc.RGNXNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank83
3Y CAGR-2.5%
5Y CAGR+6.2%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-2.5%/yr
vs +30.4%/yr prior
5Y CAGR
+6.2%/yr
Recent deceleration
Acceleration
-32.9pp
Decelerating
Percentile
P83
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$224.39M+7.6%
2024$208.52M-10.2%
2023$232.27M-4.2%
2022$242.45M+33.6%
2021$181.44M+9.1%
2020$166.29M+33.9%
2019$124.19M+48.1%
2018$83.87M+46.6%
2017$57.22M+25.8%
2016$45.48M-